Mounjaro (Tirzepatide) update

Posted on June 20th, 2025

The new weight management medication, Tirzepatide (brand name Mounjaro®), will be available to NHS patients nationally from 23 June 2025.

In Lancashire and South Cumbria, while some people may currently qualify for the medication based on national eligibility criteria, it will not be available locally just yet. Please do not contact your GP as they are currently unable to help.

Who is eligible?

The first group of people eligible under the national criteria includes individuals who:

• Have a Body Mass Index (BMI) of 40 kg/m² or more (or 37.5 kg/m² for people from minority ethnic family backgrounds)

And have at least four of the following long-term conditions:

• Non-diabetic hyperglycaemia or type two diabetes
• Hypertension (high blood pressure)
• Dyslipidaemia
• Established cardiovascular disease
• Obstructive sleep apnoea (formally diagnosed)

For more information, please visit the Lancashire & South Cumbria Integrated Commissioning Board (ICB) via this link